Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ET(A) receptor blockade in chronic heart failure patients treated with ACE inhibitors

Circulation

Volumn 94, Issue 9, 1996, Pages 2131-2137

  Love, Michael P ^a   Haynes, William G ^b   Gray, Gillian A ^b   Webb, David J ^b   McMurray, John J V ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

endothelin; heart failure; receptors; vasoconstriction; vasodilatation

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; PHOSPHORAMIDON; THIORPHAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; FEMALE; HEART FAILURE; HUMAN; LIMB BLOOD FLOW; MALE; PRIORITY JOURNAL;

EID: 0029827821     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.9.2131     Document Type: Article

References (32)

1. Dargie HJ, McMurray JJV. Diagnosis and management of heart failure. Br Med J. 1994;308:321-328.
2. Hood WB. Role of converting enzyme inhibitors in the treatment of heart failure. J Am Coll Cardiol. 1993;22(suppl A):154A-157A.
3. Dickstein K, Chang P, Willenheimer R, Haunso S, Remes J, Hall C, Kjekshus J. Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure. J Am Coll Cardiol. 1995;26:438-445.
4. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
5. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes, Proc Natl Acad Sci U S A. 1989;86:2863-2867.
6. Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet. 1994;344:852-854.
7. Hiroe M, Hirata Y, Fujita N, Umezawa S, Ito H, Tsujino M, Koike A, Nogami A, Takamoto T, Marumo F. Plasma endothelin-1 levels in idiopathic dilated cardiomyopathy. Am J Cardiol. 1991;68:1114-1115.
8. McMurray JJ, Ray SG, Abdullah I, Dargie HD, Morton JJ. Plasma endothelin in chronic heart failure. Circulation. 1992;85:1374-1379.
9. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation. 1992;85:504-509.
10. Rodeheffer RJ, Lerman A, Heublein DM, Burnett JC Jr. Increased plasma concentrations of endothelin in chronic heart failure in humans. Mayo Clin Proc. 1992;67:719-724.
11. Lerman A, Kubo SH, Tschumperlin LK, Burnett JC Jr. Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation. J Am Coll Cardiol. 1992;20:849-853.
12. Stewart DJ, Cernacek P, Costello KB, Rouleau JL. Elevated endothelin-1 in heart failure and loss of normal response to postural change. Circulation. 1992;26:510-517.
13. Pacher R, Bergler-Klein J, Globits S, Teufelsbauer H, Schuller M, Krauter A, Ogris E, Rodler S, Wutte M, Hartter E. Plasma big endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension. Am J Cardiol. 1993;71:1293-1299.
14. Cacoub P, Dorent R, Nataf P, Carayon L, Maistre G, Piette JC, Godeau P, Cabrol C, Gandjbakhch I. Plasma endothelin and pulmonary pressures in patients with congestive heart failure. Am Heart J. 1992;126:1484-1488.
15. Wei C-M, Lerman A, Rodeheffer RJ, McGregor CGA, Brandt RR, Wright S, Heublein DM, Kao PC, Edwards WD, Burnett JC Jr. Endothelin in human congestive heart failure. Circulation. 1994;89: 1580-1586.
16. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 1990;348:730-733.
17. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T. Cloning of a cDNA encoding a non-isopeptide selective subtype of the endothelin receptor. Nature. 1990;348:732-735.
18. B receptors mediate contraction to endothelin-1 in human Blood vessels. Circulation. 1994;89:1203-1208.
19. White DG, Garratt H, Mundin JW, Sumner MJ, Vallance PJ, Watts IS. Human saphenous vein contains both endothelin ETA and ETB contractile receptors. Eur J Pharmacol. 1994;257:307-310.
20. Tschudi MR, Lüscher TF. Characterization of contractile endothelin receptors and angiotensin receptors in human resistance arteries: evidence for two endothelin and one angiotensin receptor. Biochem Biophys Res Commun. 1994;204:685-690.
21. B receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation. 1995;92:357-363.
22. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension. 1995;25:918-923.
23. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M. ECE-1: a membrane bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell. 1994;78:473-485.
24. Ollins GM, Krieter PA, Trapani AJ, Spear KL, Bovy PR. Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo. Mol Cell Endocrinol. 1989;61:201-208.
25. Mumford RA, Pierzchala PA, Strauss AW, Zimmerman M. Purification of a membrane bound metalloendopeptidase from porcine kid ney that degrades peptide hormones. Proc Natl Acad Sci U S A. 1981;78:6623-6627.
26. Roques BP, Noble F, Daugé V, Fournié-Zaluski M-C, Beaumont A. Neutral endopeptidase 24.11 : structure, inhibition and experimental and clinical pharmacology. Pharmacol Rev. 1993;45:87-146.
27. Ihara M, Noguchi K, Saeki T, Fukuroda T, Tsuchida S, Kimura S, Fukami T, Ishikawa K, Nishikibe M, Yano M. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci. 1992;50:247-255.
28. Williams DL, Jones KL, Colton CD, Nutt RF. Identification of high affinity endothelin-1 receptor subtypes in human tissues. Biochem Biophys Res Commun. 1991;180:475-480.
29. Ferro CJ, Webb DJ. The clinical potential of endothelin receptor antagonists in cardiovascular medicine. Drugs. 1996;51:12-27.
30. Kiowski W, Sütsch G, Hunziker P, Muller P, Kim J, Oechslin E, Schmitt R, Jones R. Bertel O. Evidence for endothelin-1 mediated vasoconstriction in severe chronic heart failure. Lancet. 1995;346: 732-736.
31. Cannan CR, Burnett JC Jr, Lerman A. Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental congestive heart failure. Circulation. 1996;93:646-651.
32. Treasure CB, Alexander RW. The dysfunctional endothelium in heart failure. J Am Coll Cardiol. 1993;22(suppl A):129A-134A.